May is a month to recognize the importance of cancer research, with both Brain Tumor Awareness Month and National Cancer Research Month taking center stage. At the Fralin Biomedical Research Institute at VTC, we are dedicated to advancing our understanding of cancer and developing new ways to treat and prevent it.

Our teams of investigators are working tirelessly to uncover the molecular mechanisms that drive cancer growth, migration, and metastasis. We are tackling a range of cancers, from childhood cancers to breast cancer to glioblastoma, one of the deadliest forms of brain cancer.

We're not just looking for new treatments, we're also working to make existing treatments more effective by making cancer cells more vulnerable. And we're developing entirely new treatments that can halt cancer in its tracks and prevent its return.

But we don't work alone. At the Virginia Tech Cancer Research Alliance, we are collaborating with cancer scientists from across multiple universities and health centers to introduce innovative preventions, diagnostics, and therapeutics for a variety of cancers. On May 25, the second annual Virginia Tech Cancer Research Alliance Retreat will be held at the Children's National Research and Innovation Campus in Washington, D.C., where alliance members will share their research, forge new collaborations, and learn from keynote speakers spanning veterinary and human oncology and biomedical cancer research.

We're proud to be at the forefront of cancer research, and we're committed to reducing morbidity and mortality in humans and pets. Join us in recognizing the vital importance of cancer research this May, and every month.